Ensayos clínicos

8.676 ensayos encontrados

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Open-Label, Controlled Study of Cabozantinib (XL184) in Combination With Atezolizumab vs Second Novel Hormonal Therapy (NHT) in Subjects With Metastatic Castration-Resistant Prostate Cancer

INTERVENTIONALInicio: 19 de oct de 2020ID: NCT04446117

Activo, no reclutaFase 2ClinicalTrials.gov

A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With Prodromal and Early Manifest Huntington's Disease

INTERVENTIONALInicio: 3 de feb de 2023ID: NCT05686551

TerminadoFase 3ClinicalTrials.gov

A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis

INTERVENTIONALInicio: 22 de jun de 2017ID: NCT03068754

CompletadoFase 3ClinicalTrials.gov

A 24-month, Multi-center, Randomized, Open-label, Non-inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-controlled Everolimus With Reduced Cyclosporine Versus 3.0 g Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Heart Transplant Recipients

INTERVENTIONALInicio: 1 de ene de 2006ID: NCT00300274

CompletadoClinicalTrials.gov

Deep Dictionaries for Feature Extraction in Context of Sparse Data for Electroencephalographic Signals from Brain-computer Interfaces

OBSERVATIONALInicio: 2 de sept de 2024ID: NCT06861517

CompletadoClinicalTrials.gov

Study of HPV Self Testing Evaluation in the Province of Jujuy, Argentina

INTERVENTIONALInicio: 1 de jul de 2012ID: NCT02095561

CompletadoFase 3ClinicalTrials.gov

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF THE SUBCUTANEOUS ADMINISTRATION OF TANEZUMAB (PF-04383119) IN SUBJECTS WITH CANCER PAIN PREDOMINANTLY DUE TO BONE METASTASIS RECEIVING BACKGROUND OPIOID THERAPY

INTERVENTIONALInicio: 28 de oct de 2015ID: NCT02609828

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease

INTERVENTIONALInicio: 1 de dic de 2012ID: NCT01760005

CompletadoFase 4ClinicalTrials.gov

A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-naïve Patients With Type 2 Diabetes Mellitus

INTERVENTIONALInicio: 30 de mar de 2012ID: NCT01528254

CompletadoFase 3ClinicalTrials.gov

Extending Molecular Responses With Nilotinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

INTERVENTIONALInicio: 1 de abr de 2011ID: NCT01254188

CompletadoFase 3ClinicalTrials.gov

Open-Label Extension Study to Evaluate the Safety of USL255 as Adjunctive Therapy in Patients With Refractory Partial-Onset Seizures Who Had Participated in P09-004, a Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study

INTERVENTIONALInicio: 1 de oct de 2010ID: NCT01191086

CompletadoFase 1ClinicalTrials.gov

Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis

INTERVENTIONALInicio: 16 de jul de 2014ID: NCT02165345

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled, 12-month Phase 3 Study to Evaluate the Effect of Venglustat on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Who Are Treatment-naïve or Untreated for at Least 6 Months

INTERVENTIONALInicio: 11 de mar de 2022ID: NCT05206773

TerminadoFase 3ClinicalTrials.gov

A Phase 3, International, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on CKD Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

INTERVENTIONALInicio: 30 de sept de 2021ID: NCT05056727

ReclutandoFase 3ClinicalTrials.gov

TENACITY - A Phase III, Prospective, Randomized, Open-label, Blinded Endpoint Assessment (PROBE) to Assess Efficacy and Safety of i.v. Tenecteplase vs Standard of Care in Patients With Acute Ischemic Stroke (Including Wake-up Stroke), Last Known Well >4.5 h With Imaging Evidence of Salvageable Ischemic Tissue

INTERVENTIONALInicio: 17 de feb de 2026ID: NCT07361302

TerminadoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Open-Label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL)

INTERVENTIONALInicio: 26 de jul de 2011ID: NCT01287741

CompletadoFase 3ClinicalTrials.gov

SAINT (Stroke - Acute Ischemic - NXY Treatment) A Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter, Phase IIb/III Study to Assess the Efficacy and Safety of Intravenous NXY-059 in Acute Ischemic Stroke

INTERVENTIONALInicio: 1 de may de 2003ID: NCT00061022

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) Administered Subcutaneously (SC) to Subjects With Systemic Lupus Erythematosus (SLE)

INTERVENTIONALInicio: 16 de nov de 2011ID: NCT01484496

CompletadoClinicalTrials.gov

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

OBSERVATIONALInicio: 1 de ene de 2010ID: NCT01869010

CompletadoClinicalTrials.gov

A Screening Protocol to Assess Adult and Adolescent Individuals With Down Syndrome for Eligibility to Participate in an Upcoming Study to Evaluate the Efficacy, Safety and Tolerability of RG1662 (Study BP27832)

OBSERVATIONALInicio: 31 de oct de 2013ID: NCT01920633